Fetoscopic Meningomyelocele Repair Study

NCT02230072 | Completed Phase 1 DMC FDA Device

• 1 other identifier: H-34680
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 2

Brief Summary

The purpose of the study is to evaluate the maternal and fetal outcomes of a new technique for the fetoscopic repair of fetal MMC at Texas Children's Hospital Pavilion for Women. The investigators hypothesis is that this minimally invasive technique is feasible, and that this approach will have the same efficacy as open fetal surgery for MMC, but with significantly less maternal-fetal risk. Both mother and baby will benefit from the surgery. The fetus will have a repaired MMC defect, and the mother will not have a uterine incision (hysterotomy). A hysterotomy increases the risk of uterine rupture and requires that all subsequent deliveries are by cesarean section. There may also be a decreased risk of Pre-term Premature Rupture Of Membranes (PPROM) and prematurity when compared with the current open operation. Finally, a vaginal delivery is possible following the fetoscopic fetal surgery if the baby is shown to have a skin covered repair.

Conditions

Neural Tube Defect

Keywords

myelomeningocele; MMC; NTD; neural; defect; Spina bifida; Neural Tube Defect

Outcome Measures

Primary Outcomes (1)

• Feasibility

  Whether the minimally invasive technique can be technically performed in human patients (success of primary skin closure) in a safe and effective manner.

  Time of procedure

Secondary Outcomes (1)

• Reversal of the Chiari II malformation with complete closure of the spinal defect.

  at birth

Study Arms (1)

fetoscopic surgical repair

EXPERIMENTAL

Single arm study. All patients will receive the fetoscopic repair.

Device: fetoscopy

Interventions

fetoscopy DEVICE

The fetoscopic arm is described above. All patients will have a laparotomy, exteriorization of the uterus, and a fetoscopic repair of the fetal open neural tube defect.

Also known as: Karl Storz, Tuttlingen, Germany, Richard Wolf Medical Instruments, Corp., Karl Storz Endoscopy-America, Inc., Cook Medical, Inc., Lexion Medical, LLC., Terumo Pinnacle

fetoscopic surgical repair

Eligibility Criteria

• Age: 18 Years - 64 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Pregnant women - maternal age 18 years or older and capable of consenting for their own participation in this study,
• Singleton pregnancy,
• MMC with the upper boundary located between T1 and S1,
• Evidence of hindbrain herniation (confirmed on MRI to have an Arnold-Chiari type II malformation),
• Absence of chromosomal abnormalities and associated anomalies,
• Gestational age at the time of the procedure will be between 19 0/7 weeks and 25 6/7 weeks,
• Normal karyotype and/or normal chromosomal microarray (CMA) by invasive testing (amniocentesis or CVS). If there is a balanced translocation with normal MCA with no other anomalies the candidate can be included. Patients declining invasive testing will be excluded.
• Family has considered and declined the option of termination of the pregnancy at less than 24 weeks,
• Family meets psychosocial criteria (sufficient social support, ability to understand requirements of the study), and
• Parental/guardian permission (informed consent) for follow up of child after birth.

You may not qualify if:

• Fetal anomaly unrelated to MMC,
• Severe kyphosis,
• Increased risk for preterm labor including short cervical length (\<1.5 cm), history of incompetent cervix with or without cerclage, and previous preterm birth,
• Placental abnormalities (previa, abruption, accreta) known at time of enrollment,
• A pre-pregnancy body-mass index ≥40,
• Contraindications to surgery including previous hysterotomy (whether from a previous classical cesarean, uterine anomaly such as an arcuate or bicornuate uterus, major myomectomy resection, or previous fetal surgery) in active uterine segment,
• Technical limitations precluding fetoscopic surgery, such as uterine fibroids, fetal membrane separation, and uterine anomalies,
• Maternal-fetal Rh isoimmunization, Kell sensitization or neonatal alloimmune thrombocytopenia affecting the current pregnancy,
• Maternal HIV, Hepatitis-B, Hepatitis-C status positive because of the increased risk of transmission to the fetus during maternal-fetal surgery. If the patient's HIV or Hepatitis status is unknown, the patient must be tested and found to have negative results before enrollment,
• Maternal medical condition that is a contraindication to surgery or anesthesia,
• Patient does not have a support person (e.g. Spouse, partner, mother) available to support the patient for the duration of the pregnancy,
• Inability to comply with the travel and follow-up requirements of the trial,
• Participation in another intervention study that influences maternal and fetal morbidity and mortality or participation in this trial in a previous pregnancy, and
• Patient scores as severely depressed on the BDI-II questionnaire; a score of 29 or above.
• Maternal hypersensitivity to collagen.

Sponsors & Collaborators

• Baylor College of Medicine: lead

Study Sites (2)

Stanford University: Lucille Packard's Childrens Hospital

Stanford, California, 94305, United States

Location

Texas Childrens Hospital

Houston, Texas, 77030, United States

Location

Related Publications (2)

• Corroenne R, Mehollin-Ray AR, Johnson RM, Whitehead WE, Espinoza J, Castillo J, Castillo H, Orman G, Donepudi R, Huisman TAGM, Nassr AA, Belfort MA, Sanz Cortes M, Shamshirsaz AA. Impact of the volume of the myelomeningocele sac on imaging, prenatal neurosurgery and motor outcomes: a retrospective cohort study. Sci Rep. 2021 Jun 23;11(1):13189. doi: 10.1038/s41598-021-92739-2.

  PMID: 34162982 DERIVED

• Belfort MA, Whitehead WE, Shamshirsaz AA, Bateni ZH, Olutoye OO, Olutoye OA, Mann DG, Espinoza J, Williams E, Lee TC, Keswani SG, Ayres N, Cassady CI, Mehollin-Ray AR, Sanz Cortes M, Carreras E, Peiro JL, Ruano R, Cass DL. Fetoscopic Open Neural Tube Defect Repair: Development and Refinement of a Two-Port, Carbon Dioxide Insufflation Technique. Obstet Gynecol. 2017 Apr;129(4):734-743. doi: 10.1097/AOG.0000000000001941.

  PMID: 28277363 DERIVED

MeSH Terms

Conditions

Neural Tube Defects; Meningomyelocele; Spinal Dysraphism

Interventions

Fetoscopy

Condition Hierarchy (Ancestors)

Nervous System Malformations; Nervous System Diseases; Congenital Abnormalities; Congenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Prenatal Diagnosis; Diagnostic Techniques, Obstetrical and Gynecological; Diagnostic Techniques and Procedures; Diagnosis; Endoscopy; Diagnostic Techniques, Surgical; Fetal Therapies; Therapeutics; Minimally Invasive Surgical Procedures; Surgical Procedures, Operative; Obstetric Surgical Procedures

Study Officials

• Michael A. Belfort, M.D.

  Baylor College of Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: phase 1
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor and Chairman, Department of Obstetrics and Gynecology

Study Record Dates

• First Submitted: August 22, 2014
• First Posted: September 3, 2014
• Study Start: July 29, 2014
• Primary Completion: June 23, 2025
• Study Completion: June 23, 2025
• Last Updated: July 10, 2025

Record last verified: 2025-07

Locations

US (2)